Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Non-Current Assets (2021 - 2026)

Cingulate's (CINGW) quarterly Non-Current Assets came in at $2.9 million in Q2 2026, down 6.74% quarter-over-quarter from $3.1 million in Q4 2025.

Analysis

Cingulate (CINGW) Non-Current Assets (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Non-Current Assets for 6 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets changed N/A year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $11.0 million (changed N/A YoY), and the FY2025 full-year result was $3.1 million, up 39.09% from the prior year.
  • Non-Current Assets fell to $2.9 million in Q2 2026 per CINGW's latest filing, from $3.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.9 million in Q1 2022 and bottomed at $2.0 million in Q1 2025.
  • Historically, Non-Current Assets has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
  • The widest YoY moves for Non-Current Assets: up 39.09% in 2025, down 29.02% in 2025.
  • Over 5 years, Non-Current Assets stood at $3.5 million in 2022, then slipped by 17.61% to $2.9 million in 2023, then fell by 24.35% to $2.2 million in 2024, then jumped by 39.09% to $3.1 million in 2025, then decreased by 6.74% to $2.9 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $2.9 million, $3.1 million, and $3.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 141.29 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 101.45 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 94.68 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 159.77 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 113.37 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 294.93 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 1.85 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 3.74 Bn
10 Cingulate 100,214.03 100,214.03 - 2.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Dec 31, 2025 3.07 Mn
Sep 30, 2025 3.09 Mn
Mar 31, 2025 1.96 Mn
Dec 31, 2024 2.20 Mn
Sep 30, 2024 2.24 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 2.77 Mn
Dec 31, 2023 2.91 Mn
Sep 30, 2023 2.97 Mn
Jun 30, 2023 3.19 Mn
Mar 31, 2023 3.41 Mn
Dec 31, 2022 3.54 Mn
Sep 30, 2022 3.54 Mn
Jun 30, 2022 3.70 Mn
Mar 31, 2022 3.86 Mn
Dec 31, 2021 4.00 Mn